| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
62,167,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile 4D Molecular Therapeutics is a clinical-stage gene therapy company engaging the development of product candidates using its targeted and evolved adeno-associated viruses vectors. Co. has built a portfolio of gene therapy product candidates, with five product candidates in clinical trials: 4D-125 for the treatment of X-linked retinitis pigmentosa, 4D-150 for the treatment of wet age-related macular degeneration, 4D-110 for the treatment of choroideremia, 4D-310 for the treatment of Fabry disease, and 4D-710 for the treatment of cystic fibrosis lung disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
21,917 |
830,288 |
| Total Sell Value |
$0 |
$0 |
$494,364 |
$17,563,809 |
| Total People Sold |
0 |
0 |
2 |
4 |
| Total Sell Transactions |
0 |
0 |
6 |
24 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Shah Rajeev M. |
10% Owner |
– – • |
2024-12-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(535,000) |
4,563,211 |
|
- |
|
| Shah Rajeev M. |
10% Owner |
– – • |
2024-11-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,098,211 |
|
- |
|
| Lampert Mark N |
See Explanation of Responses |
– – – |
2024-11-08 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,680,000) |
87,911 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-09-16 |
4 |
AS |
$16.33 |
$8,165 |
D/D |
(500) |
6,781 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-09-16 |
4 |
OE |
$6.49 |
$3,245 |
D/D |
500 |
7,281 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-08-19 |
4 |
AS |
$15.00 |
$7,500 |
D/D |
(500) |
6,781 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-08-19 |
4 |
OE |
$6.49 |
$3,245 |
D/D |
500 |
7,281 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-07-16 |
4 |
AS |
$27.11 |
$47,443 |
D/D |
(1,750) |
6,781 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-07-16 |
4 |
OE |
$6.49 |
$13,295 |
D/D |
1,750 |
8,531 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-07-11 |
4 |
AS |
$25.00 |
$49,900 |
D/D |
(1,996) |
6,781 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-07-11 |
4 |
OE |
$15.78 |
$31,497 |
D/D |
1,996 |
8,777 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2024-07-10 |
4 |
AS |
$22.49 |
$290,598 |
D/D |
(12,923) |
1,059,153 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2024-07-10 |
4 |
OE |
$14.42 |
$188,077 |
D/D |
12,923 |
1,072,076 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-07-01 |
4 |
AS |
$21.36 |
$90,758 |
D/D |
(4,248) |
1,737 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-07-01 |
4 |
OE |
$6.49 |
$32,089 |
D/D |
4,248 |
5,985 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2024-06-24 |
4 |
AS |
$23.10 |
$298,711 |
D/D |
(12,930) |
1,059,153 |
|
- |
|
| Kirn David |
Chief Executive Officer |
• • – |
2024-06-24 |
4 |
OE |
$14.42 |
$186,451 |
D/D |
12,930 |
1,072,083 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-06-17 |
4 |
AS |
$23.71 |
$41,494 |
D/D |
(1,750) |
1,737 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-06-17 |
4 |
OE |
$6.49 |
$13,295 |
D/D |
1,750 |
3,487 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-05-16 |
4 |
AS |
$25.34 |
$44,541 |
D/D |
(1,750) |
1,737 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-05-16 |
4 |
OE |
$6.49 |
$13,295 |
D/D |
1,750 |
3,487 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-04-16 |
4 |
AS |
$25.74 |
$45,045 |
D/D |
(1,750) |
1,737 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-04-16 |
4 |
OE |
$6.49 |
$13,295 |
D/D |
1,750 |
3,487 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-04-01 |
4 |
AS |
$31.78 |
$259,102 |
D/D |
(8,153) |
1,737 |
|
- |
|
| Bizily Scott |
Chief Legal Officer |
• – – |
2024-04-01 |
4 |
OE |
$6.49 |
$102,224 |
D/D |
8,153 |
9,890 |
|
- |
|
87 Records found
|
|
Page 1 of 4 |
|
|
